New York, New York, United States Gabriel Capital Management is the famous VC, which was founded in 1994. The venture was found in North America in United States. The main department of described VC is located in the New York.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - Israel. We can highlight the next thriving fund investment areas, such as Biotechnology, Pharmaceutical. Among the various public portfolio startups of the fund, we may underline Intec Pharma Besides, a startup needs to be aged 11-15 years to get the investment from the fund.
Besides them, we counted 1 critical employee of this fund in our database.
The standard case for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are Sphera Corporation. In the next rounds fund is usually obtained by ROTH Capital Partners, Oppenheimer & Co., Inc., Ladenburg Thalmann.
The increased amount of exits for fund were in 2015. The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2013.
Funds with similar focus
| Fund Name | Location |
| 350 Capital | Canada, Ontario, Toronto |
| ABB | Switzerland, Zürich, Zurich |
| AVANA Capital | Arizona, Glendale, United States |
| Blue Cloud Ventures | New York, New York, United States |
| Cobis | Great Falls, United States, Virginia |
| Echo Capital | Canada, Montréal, Quebec |
| ENGIE New Ventures | France, Ile-de-France, Paris |
| Guosheng Group | China, Shanghai |
| Heyu Ziben | China, Guangdong, Shenzhen |
| HLM Management Company | Boston, Massachusetts, United States |
| ITX Corporation | New York, Pittsford, United States |
| Jadebird Capital | Beijing, Beijing, China |
| Manhuadao | China, Minhang, Shanghai |
| Southeast Minnesota Capital Fund | Minnesota, Rochester, United States |
| Starharbor Asia | - |
| The Arena Capital | China, Shanghai |
| Xinlan Investment | Beijing, Changping, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Intec Pharma | $5M | 19 Aug 2013 | Jerusalem District |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Intec Pharma | $5M | 19 Aug 2013 | Jerusalem District |
